Apart from Aβ and tau biomarkers, blood-based indicators of neurodegeneration in AD include total tau, GFAP, and neurofilament light chain (NfL), reflecting neuronal injury, CNS inflammation, and subcortical axonal damage, respectively. Here, MAPT is linked to Alzheimer disease.